{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:28:04Z","timestamp":1789129684734,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ctro.2026.101272","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:45:33Z","timestamp":1787931933000},"page":"101272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Post-prostatectomy magnetic resonance-guided adaptive salvage radiotherapy: early toxicity and biochemical outcomes from a prospective single center cohort"],"prefix":"10.1016","volume":"61","author":[{"given":"Spencer","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary L.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Wen","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Jameson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Kasraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101272_bb0005","author":"Cancer Australia"},{"issue":"3","key":"10.1016\/j.ctro.2026.101272_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ctro.2026.101272_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/AUO AP 09\/95 trial","volume":"66","author":"Wiegel","year":"2014","journal-title":"Eur. Urol."},{"issue":"9858","key":"10.1016\/j.ctro.2026.101272_bb0020","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101272_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.prro.2019.04.008","article-title":"Adjuvant and salvage radiation therapy after prostatectomy: ASTRO\/AUA guideline amendment, executive summary 2018","volume":"9","author":"Pisansky","year":"2019","journal-title":"Pract. Radiat. Oncol."},{"issue":"10","key":"10.1016\/j.ctro.2026.101272_bb0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jnci\/djj190","article-title":"Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"98","author":"Stephenson","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ctro.2026.101272_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/s1677-5538.ibju.2016.0656","article-title":"Biochemical recurrence after radical prostatectomy: what does it mean?","volume":"44","author":"Tourinho-Barbosa","year":"2018","journal-title":"Int. Braz. J. Urol."},{"issue":"4","key":"10.1016\/j.ctro.2026.101272_bb0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J. Urol."},{"issue":"30","key":"10.1016\/j.ctro.2026.101272_bb0045","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1200\/JCO.2016.67.9647","article-title":"Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy","volume":"34","author":"Tendulkar","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctro.2026.101272_bb0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/pros.24452","article-title":"The impact of salvage radiotherapy initiation at PSA\u2264 0.5 ng\/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy","volume":"83","author":"Lee","year":"2023","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.ctro.2026.101272_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoncol.2020.0109","article-title":"Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer","volume":"6","author":"Dess","year":"2020","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101272_bb0060","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ijrobp.2008.06.835","article-title":"Update of SWOG 8794: adjuvant radiotherapy for pT3 prostate cancer improves metastasis free survival","volume":"72","author":"Swanson","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9858","key":"10.1016\/j.ctro.2026.101272_bb0065","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ctro.2026.101272_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96\u201302\/AUO AP 09\/95 trial","volume":"66","author":"Wiegel","year":"2014","journal-title":"Eur. Urol."},{"issue":"10","key":"10.1016\/j.ctro.2026.101272_bb0075","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10260","key":"10.1016\/j.ctro.2026.101272_bb0080","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ctro.2026.101272_bb0085","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10260","key":"10.1016\/j.ctro.2026.101272_bb0090","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(20)31952-8","article-title":"Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data","volume":"396","author":"Vale","year":"2020","journal-title":"Lancet"},{"issue":"10338","key":"10.1016\/j.ctro.2026.101272_bb0095","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ctro.2026.101272_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging\u2013guided vs computed tomography\u2013guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101272_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijrobp.2024.05.028","article-title":"Patient-reported outcomes following magnetic resonance-guided radiation therapy for prostate cancer: a systematic review and meta-analysis","volume":"120","author":"Westerhoff","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"16","key":"10.1016\/j.ctro.2026.101272_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164651","article-title":"First experience and prospective evaluation on feasibility and acute toxicity of online adaptive radiotherapy of the prostate bed as salvage treatment in patients with biochemically recurrent prostate cancer on a 1.5 T MR-Linac","volume":"11","author":"Wegener","year":"2022","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.ctro.2026.101272_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14253","article-title":"Magnetic resonance guided adaptive post prostatectomy radiotherapy: accumulated dose comparison of different workflows","volume":"25","author":"Hassan","year":"2024","journal-title":"J. Appl. Clin. Med. Phys."},{"issue":"3","key":"10.1016\/j.ctro.2026.101272_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ajco.14144","article-title":"Post-prostatectomy magnetic resonance-guided radiotherapy on a 1.5 tesla magnetic resonance integrated linear accelerator: feasibility, toxicity, and preliminary clinical outcomes","volume":"21","author":"Poon","year":"2025","journal-title":"Asia-Pac. J. Clin. Oncol."},{"key":"10.1016\/j.ctro.2026.101272_bb0125","first-page":"64","article-title":"Analysis of data to advance personalised therapy with MR-linac (ADAPT-MRL)","volume":"31","author":"de Leon","year":"2021","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101272_bb0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2020.08.034","article-title":"NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer","volume":"109","author":"Hall","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101272_bb0135","doi-asserted-by":"crossref","first-page":"110690","DOI":"10.1016\/j.radonc.2024.110690","article-title":"Post-prostatectomy radiation therapy: updated guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group (FROGG)","volume":"204","author":"Warrender-Sparkes","year":"2025","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.ctro.2026.101272_bb0140","article-title":"ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer","volume":"41","author":"Dal Pra","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"10","key":"10.1016\/j.ctro.2026.101272_bb0145","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00259-017-3746-9","article-title":"Patterns of failure after radical prostatectomy in prostate cancer\u2013implications for radiation therapy planning after 68Ga-PSMA-PET imaging","volume":"44","author":"Schiller","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ctro.2026.101272_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.radonc.2019.09.007","article-title":"Patterns of recurrence after prostate bed radiotherapy","volume":"141","author":"Brand","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ctro.2026.101272_bb0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijrobp.2023.08.051","article-title":"Development of prostate bed delineation consensus guidelines for magnetic resonance image-guided radiotherapy and assessment of its effect on interobserver variability","volume":"118","author":"Sritharan","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ctro.2026.101272_bb0160","article-title":"Interim prostate-specific antigen: predicting for biochemical failure during salvage radiation therapy after prostatectomy","volume":"6","author":"Cardoso","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2026.101272_bb0165","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers14071670","article-title":"A comparison between patient-and physician-reported late radiation toxicity in long-term prostate cancer survivors","volume":"14","author":"Nuijens","year":"2022","journal-title":"Cancers"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:23:52Z","timestamp":1789125832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S2405630826001679"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101272","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-prostatectomy magnetic resonance-guided adaptive salvage radiotherapy: early toxicity and biochemical outcomes from a prospective single center cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101272"}}